Dec 29, 2025 Cagrilintide is a long-acting amylin receptor agonist that produces 10-12% body weight loss through mechanisms completely different from GLP-1s - dramatically slowing gastric emptying, suppressing appetite via brain amylin receptors, and reducing postprandial glucose
Blood test markers to discuss with a clinician Marker IGF-1 Why it matters Shows the downstream signal after GH-axis stimulation and helps frame pathway intensity
The Importance of a Specialist: This is a key symptom that should never be ignored
Cagrilintide is a long-acting amylin analogue that suppresses appetite and slows gastric emptying without touching incretin pathways
Of these, approximately 65% are 65 years of age or older and most are female
Peptide Therapies Kisspeptin CJC-1295 + Ipamorelin Tesamorelin MOTS-C for mitochondrial enhancement It can indirectly improve hormonal health by improving recovery, fat loss, and energy production